Syna

<!-- Name:DistributionId Value:8742048 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:9500 -->…

SAN JOSE, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in upcoming investor conference. Michael Hurlston, President and CEO, will present at the 25th Annual Needham…

AHMEDABAD, India, Nov. 3, 2022 /PRNewswire/ -- Syna Therapeutics, a joint venture of Reig Jofre and Leanbio, has signed a global rights licensing deal with Intas Pharmaceuticals Ltd. to commercialise its biosimilar drug LB-0702. Under…